|
Board Reviews in Hematology and Medical Oncology
(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets (http://www.researchandmarkets.com/research/8fb2c8/board_reviews_in_h) has announced the addition of the "Board Reviews in Hematology and Medical Oncology" training to their offering.
The material has been prepared by medical experts specifically trained in hematology and medical oncology in conjunction with The George Washington University Medical Center to help physicians improve their skills.
- Panel of hematology-medical oncology experts to help you prepare for your certification/recertification exam
- Aids practitioners evaluated through the ABMS Maintenance of Certification process
- Self-study program lets you learn without the expense of travel or time away from your practice. Repeat lectures as needed to reinforce learning of difficult topics
Learning Objectives
After viewing this program, participants should be able to:
- Understand red cell disorders
- Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
- Understand blood and marrow morphology and hematopathology
- Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
- Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
- Recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
- Understand the principals of management of gynecologic and other genito-urinary malignancies
- Contend with complexity of HIV related malignancies
- Recognize principles of new developments in biologic therapy of cancer
- Build core competencies as outlined in the ABMS Maintenance of Certification process
Accreditation
The George Washington University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essential Areas, Elements and Policies.
Credit Designation
The George Washington University Medical Center designates this self-study Hematology/Oncology Board Review for a maximum of 52 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Learning Process
Physician learners are expected to view/listen to all modules, reflect on their content, complete the CME self-assessment and CME evaluation, and return them to the address indicated for scoring. A processing fee must accompany the completed self-assessment and evaluation. Only upon receipt of your self-assessment, evaluation and payment will your CME certificate and correct answers to the self-assessment be mailed to you.
Estimated Time to Complete this CME Program: 52 Hours
Method of Physician Participation: Review recordings of conference sessions and apply knowledge to post-test.
Evaluation Methods: Participants will complete a self-assessment examination to test knowledge gained from viewing the program.
Grantors: The live CME activity from which this self-study CME activity is derived was supported in part by educational grants provided by:
- BiogenIDEC
- Cephalon
- Merck & Co.
- NovoNordisk
- Ortho Biotech Oncology
- OSI Pharmaceuticals
- Sanofi-Aventis
- Wyeth
A note on the available formats:
DVD: Video package includes 25 hematology/medical oncology DVDs with carrying case, 1 CD-ROM with electronic program syllabus, 1 posttest (239 questions).
CD: Audio package includes 55 hematology/medical oncology audio CDs with carrying case, 1 CD-ROM with electronic program syllabus, 1 posttest (239 questions).
*Subject to change.
Key Topics Covered:
Biology of Hematopoiesis Jerry L. Spivak, MD Professor of Medicine and Oncology, Johns Hopkins School of Medicine, Baltimore, MD
Megaloblastic and Sideroblastic Anemias Iron Deficiencies and Overload Porphyrias Anemia of Chronic Illness Victor R. Gordeuk, MD Professor of Medicine, Center for Sickle Cell Disease, Howard University Hospital, Washington, DC
ITP and Drug-related Thrombocytopenias Joel S. Bennett, MD Interim Chief, Division of Hematology/Oncology, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
RBC Enxymes, Membranes, and Metabolism Hemolytic Anemias Acute Myeloid Leukemia Imad Tabbara, MD Professor of Medicine, Division of Hematology and Oncology, The George Washington University Medical Center, Washington, DC
Molecular Diagnostic Methods of Common Hematologic Disorders Nancy Berliner, MD Chief, Division of Hematology, Brigham and Women's Hospital, Boston, MA
Mechanisms for Clotting The Hemophilias Nigel Key, MD Harold R. Roberts Professor, Director, UNC Comprehensive Hemophilia Treatment Center, Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill Chapel Hill, NC
Von Willebrand's Disease Acquired Disorders of Coagulation Margaret Rick, MD Adjunct Professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD
Hypercoagulable States Kenneth A. Bauer, MD Physician Professor, Beth Israel Deaconess Medical Center, Boston, MA
Qualitative Platelet Defects A. Koneti Rao, MD Professor of Medicine, Thrombosis Research and Pharmacology, Temple University School of Medicine, Philadelphia, PA
Sickling Disorders Hemoglobinopathies Martin H. Steinberg, MD Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA
Parenteral Antithrombotics and Thrombolytic Therapy Oral Anticoagulants and Antithrombotic Therapy B. Gail Macik, MD Associate Professor of Medicine and Pathology, Health Science Center, University of Virginia Health Science Center, Charlottesville, VA
Problems in Coagulation Craig Kessler, MD Professor of Medicine and Pathology, Chief, Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Washington, DC
Transfusion Medicine Platelet Alloimmunization Thomas Kickler, MD Professor of Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD
Aplastic Anemia Neal S. Young, MD Chief, Hematology Branch, NHLBI, Editor, Seminars in Hematology and Editor, Clinical Hematology, National Institutes of Health, Bethesda, MD
Consumptive Thrombohemorrhagic Disorders Prothrombotic Complications of Anticoagulation Theodore E. Warkentin, MD Professor, Department of Pathology and Molecular Medicine, and Department of Medicine McMaster University, Hamilton, Ontario Canada
Problems in Hemostaisis and Thrombosis Drs. Warkentin, Kessler and Siegel
Hematologic Complications of Pregnancy Robert S. Siegel, MD Professor of Medicine, Director, Division of Hematology and Oncology, The George Washington University Medical Center, Washington, DC
Myeloproliferative Diseases Ayalew Tefferi, MD Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
Pathology of Lymphomas Jeffrey L. Medeiros, MD Professor and Chair, Department of Hematopathology, MD Anderson Cancer Center, Houston, TX
Non-Hodgkin's Lymphoma Hodgkin's Disease Julie Vose, MD Neumann M. and Mildred E. Harris Professor, Chief, Section of Hematology and Oncology, Professor of Medicine, Nebraska Medical School, Omaha, NE
Chronic Lymphocytic Leukemia Susan O'Brien, MD Professor of Medicine, UT MD Anderson Cancer Center, Houston, TX Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Hagop Kantarjian, MD Professor of Medicine, Department of Leukemia, MD Anderson Cancer Center/Tumor Institute, Houston, TX
Multiple Myeloma, Plasmacytoma, MGUS S. Vincent Rajkumar, MD Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
Waldenstom's Macroglobulinemia and Amyloidosis Morie A. Gertz, MD Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
Myelodysplasia Alan F. List, MD Professor of Medicine and Chief, Hematologic Malignancies, H. Lee Moffitt Cancer Center, Tampa, FL
Morphology Review Donald Karcher, MD Professor and Acting Chair of Pathology, The George Washington University Medical Center, Washington, DC
Bone Marrow Transplantation Michael Bishop, MD Rockville, MD
Infectious Disease Afsoon Roberts, MD Associate Professor of Medicine, Department of Medicine-Division of Infectious Diseases, The George Washington University Medical Center, Washington, DC
Pharmacology I, II, and III Edward Chu, MD Professor and Chief, Section of Medical Oncology, Associate Director, Yale Cancer Center, Yale University School of Medicine, New Haven, CT
HIV Disease Richard Little, MD Oncologist, Bethesda, MD
Neuro-Oncology and Metastatic Disease to the Brain, Spine and Carcinomatous Meningitis Howard Fine, MD Graduate of University of Pennsylvania, Philadelphia, PA; Graduate of Mount Sinai School of Medicine, New York, NY; Chief, Neuro-Oncology Branch, National Cancer Institute (NCI), National Institutes of Health (NIH); Adjunct Investigator, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH); Adjunct Professor, North Carolina State University; and Adjunct Professor, The George Washington University School of Medicine and Health Sciences
Head and Neck Cancer David J. Adelstein, MD Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, OH
Non-Small Cell Lung Cancer Thomas Lynch, MD Medical Director, Center for Thoracic Cancers, Center of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
Small Cell Lung Cancer Bruce Johnson, MD Program Director, Lowe Center for Thoracic Oncology, Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA
Familial Cancer Syndromes Judy Garber, MD, MPH Associate Professor of Medicine, Harvard Medical School, Director, Cancer Risk and Prevention Program, Dana-Farber Cancer Center, Boston, MA
Adjuvant Therapy for Breast Cancer Nancy E. Davidson, MD Professor of Oncology, Director, Breast Cancer Program, Johns Hopkins University School of Medicine, Baltimore, MD
Treatment of Metastatic Breast Cancer Daniel F. Hayes, MD Professor of Internal Medicine, Co-Director, Breast Care Center, Clinical Director, Breast Cancer Program, University of Michigan, Ann Arbor, MI
Expert Panel: Problems in Treating Breast Cancer Drs. Siegel and Hayes
Melanoma Lynn Schucter, MD Professor of Medicine, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
Sarcomas Robert Maki, MD, PhD Co-Director, Adult Sarcoma Program and Assistant Member, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
Endocrine Malignancies Joshua L. Cohen, MD Associate Professor of Medicine, Division of Endocrinology and Metabolism, The George Washington University Medical Center, Washington, DC
Testicular Cancer and Mediastinal Germ Cell Tumors Patrick J. Loehrer, MD Director and Bruce Kenneth Wiseman Professor of Medicine, Department of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN
Renal Cell Cancer Bladder Cancer Dean Bajorin, MD Attending Physician and Member, Genitourinary Oncology Services, Memorial Sloan-Kettering Cancer Center, Professor of Medicine, Weil Medical College of Cornell University, New York, NY
Prostrate Cancer Philip Kantoff, MD Professor of Medicine, Harvard Medical School, Chief, Division of Solid Tumor Oncology, Dana Farber Cancer Institute, Boston, MA
Ovarian Cancer Endometrial Tumors J. Tate Thigpen, MD Professor of Medicine and Director, Division of Medical Oncology, University of Mississippi Medical Center, Jackson, MS
Trophoblastic Tumors Cancer of the Cervix, Vagina, Vulva Daniel Clarke-Pearson, MD Robert A. Ross Distinguished Professor and Chairman, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC
Esophageal Cancer David Ilson, MD Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Gastric Cancer Rectal Cancer Anal Cancer John Macdonald, MD Chief Medical Officer, Aptium Oncology, Inc., New York, NY
Pancreatic Cancer Mesothelioma Hedy Lee Kindler, MD Associate Professor of Medicine, Director, Gastrointestinal Oncology, Director, Mesothelioma Program, University of Chicago, Chicago, IL
Small Bowel Cancer Carcinoid James D. Ahlgren, MD Professor of Medicine, Division of Hematology and Medical Oncology, The George Washington University Medical Center, Washington, DC
Adjuvant Therapy for Colon Cancer Hepatobiliary Cancer Daniel Haller, MD Professor of Medicine, Abramson Cancer Center of the University of Pennsylvania Medical Center, Philadelphia, PA
Metastatic Colon Cancer John Marshall, MD Associate Professor of Medicine Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Washington, DC
For more information visit http://www.researchandmarkets.com/research/8fb2c8/board_reviews_in_h
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.
